Rituximab vs. Tocilizimab for Scleroderma: Which is Better? Save Jun 14, 2024 11:59 am Dr. Janet Pope discusses abstract OP0295 presented at Eular 2024 in Vienna, Austria. ADD THE FIRST COMMENT If you are a health practitioner, you may Login/Register to comment.Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.
If you are a health practitioner, you may Login/Register to comment.
Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.